Kode Technology – a universal cell surface glycan modification technology

References

• Abdel-Motal UM, Wigglesworth K, Galili U. 2009. Intratumoural injection of α-gal glycolipids induces a protective anti-tumour T cell response which overcomes Treg activity. Cancer Immunology, Immunotherapy. 58(10):1545–1556. doi: 10.1007/s00262-009-0662-2
   PubMed Web of Science ®Google Scholar
• Barr K, Korchagina E, Popova I, Bovin N, Henry S. 2015. Monoclonal anti-A activity against the FORS1 (Forssman) antigen. Transfusion. 55:129–136. doi: 10.1111/trf.12773
   PubMed Web of Science ®Google Scholar
• Barr K, Korchagina E, Ryzhov I, Bovin N, Henry S. 2014. Mapping the fine specificity of ABO monoclonal reagents with A and B type-specific function-spacer-lipid constructs in kodecytes and inkjet printed on paper. Transfusion. 54:2477–2484. doi: 10.1111/trf.12661
   PubMed Web of Science ®Google Scholar
• BiolineRx. 2018. Press Release August 1, 2018. BioLineRx Initiates Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors www.biolinerx.com/default.asp?pageid=16&itemid=617.
   Google Scholar
• Blake DA, Bovin NV, Bess D, Henry SM. 2011. FSL Constructs: A simple method for modifying cell/virion surfaces with a range of biological markers without affecting their viability. Journal of Visualized Experiments. Aug 5(54):e3289. (http://www.jove.com/details.php?id=3289).
   Google Scholar
• Chevalier L, Selim J, Genty D, Baste JM, Piton N, Boukhalfa I, Hamzaoui M, Pareige P, Richard V. 2017. Electron microscopy approach for the visualization of the epithelial and endothelial glycocalyx. Morphologie. 101:55–63. doi: 10.1016/j.morpho.2017.04.001
   PubMedGoogle Scholar
• Cowley H, Wojda U, Cipolone KM, Procter JL, Stroncek DF, Miller JL. 1999. Biotinylation modifies red cell antigens. Transfusion. 39(2):163–168. doi: 10.1046/j.1537-2995.1999.39299154730.x
   PubMed Web of Science ®Google Scholar
• Dane MJC, van den Berg BM, Lee DH, Boels MGS, Tiemeier GL, Avramut MC, van Zonneveld AJ, van der Vlag J, Vink H, Rabelink TJ. 2015. A microscopic view on the renal endothelial glycocalyx. American Journal of Physiology-Renal Physiology. 308:F956–F966. doi: 10.1152/ajprenal.00532.2014
   PubMed Web of Science ®Google Scholar
• Dube DH, Bertozzi CR. 2003. Metabolic oligosaccharide engineering as a tool for glycobiology. Current Opinion in Chemical Biology. 7:616–625. doi: 10.1016/j.cbpa.2003.08.006
   PubMed Web of Science ®Google Scholar
• Ebong EE, Macaluso FP, Spray DC, Tarbell JM. 2011. Imaging the Endothelial Glycocalyx In Vitro by Rapid Freezing/Freeze Substitution Transmission Electron Microscopy. Arteriosclerosis. Thrombosis and Vascular Biology. 31:1908–1915. doi: 10.1161/ATVBAHA.111.225268
   PubMed Web of Science ®Google Scholar
• Fink J, Seibel J. 2018. Click reactions with functional sphingolipids. Biological Chemistry. Jun 19. pii: /j/bchm.ahead-of-print/hsz-2018-0169/hsz-2018-0169.xml. doi:10.1515/hsz-2018-0169.
   PubMed Web of Science ®Google Scholar
• Frame T, Carroll T, Korchagina E, Bovin N, Henry S. 2007. Synthetic glycolipid modification of red blood cell membranes. Transfusion. 47:876–882. doi: 10.1111/j.1537-2995.2007.01204.x
   PubMed Web of Science ®Google Scholar
• Galili U. 2013. In situ conversion of tumours into autologous tumour-associated antigen vaccines by intratumoral injection of α-gal glycolipids. OncoImmunology. 2(1). Article: e22449. doi: 10.4161/onci.22449
   PubMed Web of Science ®Google Scholar
• Galili U. 2015. Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys. Journal of Molecular Evolution. 80(1):1–9. doi: 10.1007/s00239-014-9652-x
   PubMed Web of Science ®Google Scholar
• Galili U, Anaraki F. 1995. α-galactosyl (Galα1-3Galβ1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate α1,3galactosyltransferase expressed in E.coli. Glycobiology. 5(8):775–782. doi: 10.1093/glycob/5.8.775
   PubMed Web of Science ®Google Scholar
• Georgakopoulos T, Komarraju S, Henry S, Bertolini J. 2012. An improved Fc function assay utilising CMV antigen coated red blood cells generated with synthetic Function-Spacer-Lipid constructs. Vox Sanguinis. 102:72–78. doi: 10.1111/j.1423-0410.2011.01512.x
   PubMed Web of Science ®Google Scholar
• Hadac EM, Federspiel MJ, Chernyy E, Tuzikov A, Korchagina E, Bovin NV, Russell S, Henry SM. 2011. Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions. Journal of Virological Methods. 176:78–84. doi: 10.1016/j.jviromet.2011.06.005
   PubMed Web of Science ®Google Scholar
• Harrison AL, Henry S, Mahfoud R, Manis A, Albertini A, Gaudin Y, Lingwood CA, Branch DR. 2011. A novel VSV/HIV pseudotype approach for the study of HIV microbicides without requirement for level 3 biocontainment. Future Virology. 6(10):1241–1259. doi: 10.2217/fvl.11.88
   Web of Science ®Google Scholar
• Harrison AL, Olsson ML, Jones BR, Ramkumar S, Sakac D, Binnington B, Henry S, Lingwood CA, Branch DR. 2010. A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms. Glycobiology. 27:515–524.
   Google Scholar
• Heathcote D, Carroll T, Wang JJ, Flower R, Rodionov I, Tuzikov A, Bovin N, Henry S. 2010. Novel antibody screening cells, MUT + Mur kodecytes, created by attaching peptides onto erythrocytes. Transfusion. 50:635–641. doi: 10.1111/j.1537-2995.2009.02480.x
   PubMed Web of Science ®Google Scholar
• Heider S, Dangerfield JA, Metzner C. 2016. Biomedical applications of glycosylphosphatidylinositol-anchored proteins. Journal of Lipid Research. 57(10):1778–1788. doi: 10.1194/jlr.R070201
   PubMed Web of Science ®Google Scholar
• Henry S. 2009. Modification of red blood cells for laboratory quality control use. Current Opinion in Hematology. 16(6):467–472. doi: 10.1097/MOH.0b013e328331257e
   PubMed Web of Science ®Google Scholar
• Henry S, Perry H, Bovin N. 2018b. Applications for kodecytes in immunohematology. ISBT Science Series. 13:229–237. doi: 10.1111/voxs.12403
   Google Scholar
• Henry S, Williams E, Barr K, Korchagina E, Tuzikov A, Ilyushina N, Abayzeed SA, Webb KF, Bovin N. 2018a. Rapid one-step biotinylation of biological or non-biological surfaces. Scientific Reports. 8:2845. doi: 10.1038/s41598-018-21186-3
   PubMed Web of Science ®Google Scholar
• Henry SM, Komarraju S, Heathcote D, Rodinov I. 2011. Designing peptide-based FSL constructs to create Miltenberger kodecytes. ISBT Science Series. 6:306–312. doi: 10.1111/j.1751-2824.2011.01505.x
   Google Scholar
• Huai G, Qi P, Yang H, Wang Y. 2016. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation. International Journal of Molecular Medicine. 37:11–20. doi: 10.3892/ijmm.2015.2397
   PubMed Web of Science ®Google Scholar
• Huang ML, Smith RAA, Trieger GW, Godula K. 2014. Glycocalyx remodeling with proteoglycan mimetics promotes neural specification in embryonic stem cells. Journal of American Chemical Society. 136:10565–10568. doi: 10.1021/ja505012a
   PubMed Web of Science ®Google Scholar
• Huang X, Leroux J-C, Castagner B. 2017. Well-defined multivalent ligands for hepatocytes targeting via asialoglycoprotein receptor. Bioconjugate Chemistry. 28:283–295. doi: 10.1021/acs.bioconjchem.6b00651
   PubMed Web of Science ®Google Scholar
• Hult AK, Frame T, Chesla S, Henry S, Olsson ML. 2012. Flow cytometry evaluation of red blood cells mimicking naturally-occurring ABO subgroups following modification with variable amounts of FSL-A and B constructs. Transfusion. 52:247–251. doi: 10.1111/j.1537-2995.2011.03268.x
   PubMed Web of Science ®Google Scholar
• Ilyushina NA, Chernyy ES, Korchagina EY, Gambaryan AS, Henry SM, Bovin NV. 2014. Labeling of influenza viruses with synthetic fluorescent and biotin-labeled lipids. Virologica Sinica. 29(4):199–210. doi: 10.1007/s12250-014-3475-1
   PubMedGoogle Scholar
• Jesus C, Hesse C, Rocha C, Osório N, Valado A, Caseiro A, Gabriel A, Svensson L, Moslemi A-R, Siba WA, et al. 2016. Prevalence of antibodies to a new histo-blood system: the FORS system. Blood Transfusion. epub. doi 10.2450/2016.0120-16
   PubMed Web of Science ®Google Scholar
• Klein HG, Anstee DJ. 2013. Mollison’s blood transfusion in clinical medicine. Somerset: Wiley.
   Google Scholar
• Korchagina E, Tuzikov A, Formanovsky A, Popova I, Henry S, Bovin N. 2012. Toward creating cell membrane glycolandscapes with glycan lipid constructs. Carbohydrate Research. 356:238–246. doi: 10.1016/j.carres.2012.03.044
   PubMed Web of Science ®Google Scholar
• Korchagina Y, Henry SM. 2015. Synthetic glycolipid­like constructs as tools for glycobiology research, diagnostics, and as potential therapeutics. Biochemistry (Moscow). 80:857–871. doi: 10.1134/S0006297915070068
   PubMed Web of Science ®Google Scholar
• Kristian SA, Shaw SM, Wigglesworth K, Middleton J, Glossop M, Whalen GF, Old R, Galili U, Westby M, Pickford C. 2016. AGI-134, a fully synthetic α-Gal-based cancer immunotherapy: synergy with an anti-PD-1 antibody and pre-clinical pharmacokinetic and toxicity profiles. Journal of Clinical Oncology. 34(suppl):3083. doi: 10.1200/JCO.2016.34.15_suppl.3083
   Google Scholar
• Lan C-C, Blake D, Henry S, Love DR. 2012. Fluorescent Function-Spacer-Lipid construct labelling allows for real-time in vivo imaging of cell migration and behaviour in zebrafish (Danio rerio.). Journal of Fluorescence. 22:1055–1063. doi: 10.1007/s10895-012-1043-3
   PubMed Web of Science ®Google Scholar
• Marcus DM, Cass LE. 1969. Glycosphingolipids with Lewis blood group activity: Uptake by human erythrocytes. Science. 164:553–555. doi: 10.1126/science.164.3879.553
   PubMed Web of Science ®Google Scholar
• Middleton JL, Schulz O, Charlemagne A, Kristian SA, Shaw S. 2017. The novel α-Gal-based immunotherapy AGI-134 invokes CD8+ T cell-mediated immunity by driving tumour cell destruction, phagocytosis and tumour-associated antigen cross-presentation via multiple antibody-mediated effector functions (abstract nr 616) AACR. Cancer Research. 77(13 Suppl). doi:10.1158/1538-7445.AM2017-616.
   Google Scholar
• Mulivor W, Lipowsky HH. 2002. Role of glycocalyx in leukocyte-endothelial cell adhesion. American Journal of Physiology-Heart and Circulatory Physiology. 283:H1282–H1291. doi: 10.1152/ajpheart.00117.2002
   PubMed Web of Science ®Google Scholar
• Oliver C, Blake D, Henry S. 2011a. In vivo neutralization of anti-A and successful transfusion of a antigen incompatible red cells in an animal model. Transfusion. 51:2664–2675. doi: 10.1111/j.1537-2995.2011.03184.x
   PubMed Web of Science ®Google Scholar
• Oliver C, Blake D, Henry S. 2011b. Modeling transfusion reactions and predicting in vivo cell survival with kodecytes. Transfusion. 51:1723–1730. doi: 10.1111/j.1537-2995.2010.03034.x
   PubMed Web of Science ®Google Scholar
• Olsson ML, Clausen H. 2007. Modifying the red cell surface: towards an ABO-universal blood supply. British Journal of Haematology. 140:3–12.
   PubMed Web of Science ®Google Scholar
• Oriol R, Le Pendu J, Mollicone R. 1986. Genetics of ABO, H, Lewis, X and related antigens. Vox Sanguinis. 51(3):161–171. doi: 10.1111/j.1423-0410.1986.tb01946.x
   PubMed Web of Science ®Google Scholar
• Perry H, Bovin N, Henry S. 2016b. Antibody complement-mediated hemolytic studies with kodecytes reveal human complement utilized in the classical pathway is more stable than generally accepted. Transfusion. 56:2495–2501. doi: 10.1111/trf.13719
   PubMed Web of Science ®Google Scholar
• Perry H, Henry SM. 2016a. Standardized blood group A kodecytes allow for determination of anti-A,B titres without the need for sample dilution (SP248). AABB Florida, October 2016, Transfusion. S4, 3A-262.
   Google Scholar
• Ryzhov IM, Korchagina EY, Tuzikov AB, Popova IS, Tyrtysh TV, Pazynina GV, Henry SM, Bovin NV. 2016. Function-Spacer-Lipid constructs of Lewis and chimeric Lewis/ABH glycans. Synthesis and use in serological studies. Carbohydrate Research. 435:83–96. doi: 10.1016/j.carres.2016.09.016
   PubMed Web of Science ®Google Scholar
• Ryzhov IM, Tuzikov AB, Perry H, Korchagina EY, Bovin NV. 2018. Blood Group O → A transformation by chemical ligation of erythrocytes. ChemBioChem. in press. doi: 10.1002/cbic.201800289
   PubMed Web of Science ®Google Scholar
• Sneath JS, Sneath PHA. 1955. Transformation of Lewis groups of human red cells. Nature. 176:172. doi: 10.1038/176172a0
   PubMed Web of Science ®Google Scholar
• Solís D, Bovin NV, Davis AP, Jiménez-Barbero J, Romero A, Roy R, Smetana Jr K, Gabius H-J. 2015. A guide into glycosciences: how chemistry, biochemistry and biology cooperate to crack the sugar code. Biochimica et Biophysica Acta (General subjects). 1850:186–235. doi: 10.1016/j.bbagen.2014.03.016
   PubMed Web of Science ®Google Scholar
• Stephan MT, Irvine DJ. 2011. Enhancing cell therapies from the outside in: cell surface engineering using synthetic nanomaterials. Nano Today. 6(3):309–325. doi: 10.1016/j.nantod.2011.04.001
   PubMed Web of Science ®Google Scholar
• Storry JR, Castilho L, Daniels G, Flegel WA, Garratty G, de Haas M, Hyland C, Lomas-Francis C, Moulds JM, Nogues N, et al. 2014. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012). Vox Sanguinis. 107:90–96. doi: 10.1111/vox.12127
   PubMed Web of Science ®Google Scholar
• Svensson L, Hult AK, Stamps R, Angstršm J, Teneberg S, Jorgensen R, Rydberg L, Henry SM, Olsson ML. 2013. Forssman expression on human erythrocytes: Biochemical and genetic evidence of a new histo-blood group system. Blood. 121:1459–1468. doi: 10.1182/blood-2012-10-455055
   PubMed Web of Science ®Google Scholar
• Tarbell JM, Cancel LM. 2016. The glycocalyx and its significance in human medicine. Journal of Internal Medicine. 280(1):97–113. doi: 10.1111/joim.12465
   PubMed Web of Science ®Google Scholar
• Tesfay MZ, Krik A, Hadac EM, Griesmann GE, Federspiel MJ, Barber GN, Henry SM, Peng K-W, Russell SJ. 2013. PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized mice. Journal of Virology. 87:3752–3759. doi: 10.1128/JVI.02832-12
   PubMed Web of Science ®Google Scholar
• Tuzikov AB, Gambaryan AS, Juneja LR, Bovin NV. 2000. Conversion of complex oligosaccharides into polymeric conjugates and their anti-influenza virus inhibitory potency. Journal of Carbohydrate Chemistry. 19:1191–1200. doi: 10.1080/07328300008544143
   Web of Science ®Google Scholar
• Varki A, Lowe JB. 2017. Biological roles of Glycans. Glycobiology. 27:3–49.
   Google Scholar
• Voet D, Voet JG. 2011. Biochemistry. 4th ed. Chapter 12 Lipids and Membranes. Hoboken, N.J.: John Wiley & Sons.
   Google Scholar
• Williams E, Barr K, Korchagina E, Tuzikov A, Henry S, Bovin N. 2016a. Ultra-fast glyco-coating of non-biological surfaces. International Journal of Molecular Sciences. 17(1):118. doi: 10.3390/ijms17010118
   Web of Science ®Google Scholar
• Williams E, Korchagina E, Frame T, Ryzhov I, Bovin N, Henry S. 2016b. Glycomapping the fine specificity of monoclonal and polyclonal Lewis antibodies with type-specific kodecytes and FSL constructs printed on paper. Transfusion. 56:325–333. doi: 10.1111/trf.13384
   PubMed Web of Science ®Google Scholar